Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
biotech
boston blog main
deals
3
×
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
alnylam pharmaceuticals
boston top stories
clinical trials
fda
novartis
san francisco blog main
san francisco top stories
sanofi
sickle cell disease
startups
abbvie
akouos
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
azacitidine
beta-thalassemia
biogen
bluerock therapeutics
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
dacogen
What
medicines
3
×
deal
new
acquire
acquisitions
agreed
aims
announced
approach
based
billion
bio
biotech
brings
called
cash
ceo
cholesterol
collabs
company
compound
covid
daniel
debuts
developing
drug
drugs
epigenetic
epigenetics
fda
field
flagship’s
gilead
gilead’s
help
introduce
ipo
medco
month
morning
Language
unset
3
×
Current search:
medicines
×
photo
×
unset
×
deals
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further